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As one of the highest-volume vascular 
practices on the East Coast, the 
Jefferson Vascular Center (JVC) brings 
together the physicians, surgeons 
and pharmacists needed to deliver 
coordinated, convenient patient care. 
The JVC’s integrated, multi-disciplinary 
approach is extremely effective in 
diagnosing, treating and monitoring 
vascular diseases (diseases of blood 
vessels) and thrombotic (blood-
clotting) disorders – including complex 
arterial and vein thrombosis, peripheral 
artery disease, lymphedema, post-
thrombotic syndromes, chronic venous 
insufficiency, varicose veins, vasculitis 
and congenital vascular conditions. 
Launched in 2009, the JVC is led by 
Co-Directors Paul J. DiMuzio, MD, 
FACS, the William M. Measey Professor 
of Surgery and Director of the Division 
of Vascular and Endovascular Surgery, 
Geno Merli, MD, Senior Associate Chief 
Medical Officer of Thomas Jefferson 
University Hospital (TJUH), and Laurence 
Needleman, MD, Associate Professor of 
Radiology and Director of the Division 
of Abdominal Imaging. Dr. Merli has 
long been a nationally recognized 
expert in deep vein thrombosis (DVT), a 
potentially deadly blood clot in the leg. 
Housed on the sixth floor of the 
Gibbon Building at 11th and Chestnut 
Streets, the JVC recently completed a 
renovation that tripled its footprint and 
brought the angioplasty center, staffed 
by an interventional cardiologist, in close 
proximity. JVC faculty members also 
care for patients at Methodist Hospital 
and in Northeast Philadelphia, serving a 
total of about 1,500 patients annually.
As a medical specialty, vascular medicine 
is relatively new. Jefferson’s Taki Galanis, 
MD, received Board certification in 
vascular medicine by being sponsored 
and mentored into the specialty. More 
recently, physicians have been able to 
pursue fellowship training. One such 
specialist is Luis H. Eraso, MD, who 
joined Jefferson in June 2011 after 
completing three years of fellowship 
training at the Cardiovascular Division 
of the Hospital of the University of 
Pennsylvania. Dr. Eraso, who received 
Jefferson’s Marjorie A. Bowman, MD, 
’76 Early Career Investigator Award for 
Primary Care Research for his work on 
novel biomarkers of peripheral arterial 
disease, emphasizes the value of an 
integrated, multi-disciplinary center.
“Other programs offer treatment for 
problems affecting the arterial, venous 
and lymphatic circulatory systems, but 
very few do so in one physical location,” 
he says. “The Jefferson Vascular Center 
brings together medical, surgical and 
pharmacy specialists, which offers 
benefits to patients and improvement  
in care coordination and delivery.” 
Collaboration is Key to Treating Complex 
Vascular Diseases and Conditions 
Drs. Taki Galanis, Geno Merli, Walter Kraft, and Luis Eraso, comprise the vascular medicine component of the 
Jefferson Vascular Center–now caring for patients in Center City, Methodist Hospital, and Northeast Philadelphia.
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Vascular medicine physicians also 
manage the vascular wound care 
program, an integral part of the JVC 
which provides advanced vascular 
wound services, such as multilayer 
compression and absorbent 
dressing (MCAD) therapy, outpatient 
surgical debridement, application 
of bioengineered skin grafts and 
substitutes, and/or use of hyperbaric 
oxygen therapy. Additionally, some 
of the certified vascular medicine 
physicians are involved in the 
interpretation of vascular ultrasound 
studies performed at the JVC vascular 
laboratory.
Equally important, Dr. Eraso says,  
are the roles of Walter Kraft, MD,  
who is board certified in both internal 
medicine and clinical pharmacology, 
and Lynda Thomson, PharmD, who 
joins the vascular medicine physicians 
in staffing the Jefferson Anticoagulation 
and Thrombosis Service (JATS). JATS is 
a busy inpatient and outpatient consult 
service dedicated to coordinating 
the transition of care as patients with 
complex vascular conditions move 
back into community-based primary 
care. JATS also provides guidance in 
the medical management of venous 
thromboembolic disease in special 
populations, including pregnant patients. 
Working closely with Maternal-Fetal 
Medicine, Jefferson’s high-risk obstetrics 
team, the medical and pharmacy 
staff at the JVC helps to manage 
anticoagulation therapy throughout  
their pregnancy. 
“Our multi-disciplinary approach helps 
prevent overlap in care—ensuring that 
two specialties within the same system 
aren’t dealing with the same disease in 
different ways,” he concludes. “Here, 
multiple specialists practice side by 
side. We consult with each other 
and collaborate in real time, which 
enables us to provide a more seamless 
experience and support better outcomes 
for our patients.” 
For more information about the JVC, 
please visit Jefferson.edu/JVC
“Patients with extensive acute deep vein 
thrombosis (DVT) of the legs provide 
an excellent example of why effective 
medical-surgical collaboration is so 
important.
“These patients typically benefit from 
emergency catheter-directed thromboly-
sis, an endovascular procedure performed 
by vascular surgeons. Subsequent medical 
management is directed toward pre-
venting re-thrombosis and preventing 
the long-term complications of DVT. At 
the Jefferson Vascular Center, vascular 
medicine specialists initiate and transition 
that care, as well as provide long-term 
management of blood thinners and other 
medical measures. 
“Across vascular diseases and conditions, 
Jefferson’s vascular medicine specialists 
provide many outpatient services. In 
addition to the excellent care they afford, 
this collaboration allows the surgeons 
to focus on complex surgical and 
endovascular procedures.”
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